(Q35077248)

6 August 2017

1 reference

title

A review of compounds exhibiting anti-orthopoxvirus activity in animal models (English)

1 reference

6 August 2017

1

Donald F Smee

1 reference

6 August 2017

Robert W Sidwell

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

57

1 reference

6 August 2017

issue

1-2

1 reference

6 August 2017

page(s)

41-52

1 reference

Inhibition of Experimental Deoxyribonucleic Acid Virus-Induced Encephalitis by 9-β- d -Arabinofuranosylhypoxanthine 5′-Monophosphate

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone in mice infected with rabbit-pox virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

New antiviral chemotherapeutic agent active against smallpox infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Prophylaxis of smallpox with methisazone

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Vaccinia virus infection of the rabbit cornea

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Topical cidofovir for severe molluscum contagiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Cidofovir in the treatment of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Protection of rabbits against local vaccinia virus infection by Brucella abortus and polyacrylic acid in the absence of systemic interferon production

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Broad-spectrum antiviral activity of adenosine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Failure of cytosine arabinoside in treating smallpox. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Methisazone in prevention of variola minor among contacts.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Phosphonoacetic acid treatment of shope fibroma and vaccinia virus skin infections in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Field trials of methisazone as a prophylactic agent against smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

1 reference

7 January 2021

Treatment of vaccinial keratitis with vidarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of Vaccinial keratitis with trifluorothymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Progressive vaccinia treated with ribavirin and vaccinia immune globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of poxvirus infections in rabbits with 9-beta-D-arabinofuranosyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of Variola Major with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Synthesis and antiviral evaluation of analogs of adenosine-N1-oxide and 1-(Benzyloxy)adenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Strengthening national preparedness for smallpox: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Topical treatment of vaccinia virus infection with an interferon inducer in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Experimental vaccinial keratoconjunctivitis. Effect of an interferon inducer (polyI:C)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

THE BEHAVIOR OF POX VIRUSES IN THE RESPIRATORY TRACT : I. THE RESPONSE OF MICE TO THE NASAL INSTILLATION OF VACCINIA VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

The laboratory and clinical assessment of an isothiazole thiosemicarbazone (M 2 b 7714) against pox viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

An isothiazole thiosemicarbazone in the treatment of variola major in man. A controlled clinical trial and laboratory investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Assessment of an isothiazole thiosemicarbazone in the prophylaxis of contacts of variola major

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Observations on antiviral activity of netropsin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Viral Keratitis-Inhibitory Effect of 9-β- d -Arabinofuranosylhypoxanthine 5′-Monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

A New Antiviral Agent : 4-Bromo-3-methylisothiazole-5-carboxaldehyde thiosemicarbazone, M and B 7714

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Protection of mice against vaccinia virus by administration of benzaldehyde thiosemicarbazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Effect of aliphatic oxime and isatin thisemicarbazones on vaccinia infection in the mouse and in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Chemotherapeutic prevention of complications caused by vaccinia virus-vectored immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Respiratory infection of mice with vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Synthesis and antiviral activity evaluation of 3'-fluoro-3'-deoxyribonucleosides: broad-spectrum antiviral activity of 3'-fluoro-3'-deoxyadenosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Branched-chain sugar nucleosides. V. Synthesis and antiviral properties of several branched-chain sugar nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

Treatment of Fatal Disseminated Vaccinia Virus Infection in Immunosuppressed Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900199-7

7 January 2021

10.1016/S0166-3542(02)00199-7

Identifiers

DOI

1 reference

6 August 2017

1 reference